CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
29 hedge funds and large institutions have $18.2M invested in Cymabay Therapeutics in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
68% less capital invested
Capital invested by funds: $56.7M → $18.2M (-$38.6M)
Holders
29
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$602K | |
| 2 | +$124K | |
| 3 | +$102K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$67.3K |
| 5 |
JPMorgan Chase & Co
New York
|
+$67K |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$1.09M | |
| 3 | -$893K | |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$700K |
| 5 |
VAM
Visium Asset Management
New York
|
-$546K |